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Abstract. 
 
Rho-associated kinase (Rho-kinase), which 
is activated by the small GTPase Rho, phosphorylates 
myosin-binding subunit (MBS) of myosin phosphatase 
and thereby inactivates the phosphatase activity in 
vitro. Rho-kinase is thought to regulate the phosphory-
lation state of the substrates including myosin light 
chain (MLC), ERM (ezrin/radixin/moesin) family pro-
teins and adducin by their direct phosphorylation and 
by the inactivation of myosin phosphatase. Here we 
identiﬁed the sites of phosphorylation of MBS by Rho-
kinase as Thr-697, Ser-854 and several residues, and 
prepared antibody that speciﬁcally recognized MBS 
phosphorylated at Ser-854. We found by use of this anti-
body that the stimulation of MDCK epithelial cells with 
tetradecanoylphorbol-13-acetate (TPA) or hepatocyte 
growth factor (HGF) induced the phosphorylation of 
MBS at Ser-854 under the conditions in which mem-
brane rufﬂing and cell migration were induced. Pre-
treatment of the cells with 
 
Botulinum
 
 C3 ADP-ribosyl-
transferase (C3), which is thought to interfere with Rho 
functions, or Rho-kinase inhibitors inhibited the TPA- 
or HGF-induced MBS phosphorylation. The TPA stim-
ulation enhanced the immunoreactivity of phosphory-
lated MBS in the cytoplasm and membrane rufﬂing 
area of MDCK cells. In migrating MDCK cells, phos-
phorylated MBS as well as phosphorylated MLC at Ser-
19 were localized in the leading edge and posterior re-
gion. Phosphorylated MBS was localized on actin stress 
ﬁbers in REF52 ﬁbroblasts. The microinjection of C3 or 
dominant negative Rho-kinase disrupted stress ﬁbers 
and weakened the accumulation of phosphorylated 
MBS in REF52 cells. During cytokinesis, phosphory-
lated MBS, MLC and ERM family proteins accumu-
lated at the cleavage furrow, and the phosphorylation 
level of MBS at Ser-854 was increased. Taken together, 
these results indicate that MBS is phosphorylated by 
Rho-kinase downstream of Rho in vivo, and suggest 
that myosin phosphatase and Rho-kinase spatiotempo-
rally regulate the phosphorylation state of Rho-kinase 
substrates including MLC and ERM family proteins in 
vivo
 
 
 
in a cooperative manner.
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E
 
VIDENCE
 
 is accumulating that the small GTPase
Rho plays crucial roles in the regulation of various
cellular functions including stress fiber and focal
adhesion formation (Ridley and Hall, 1992, 1994), smooth
muscle contraction (Hirata et al., 1992; Gong et al., 1996),
neurite retraction (Nishiki et al., 1990; Jalink et al., 1994),
microvilli formation (Shaw et al., 1998), cytokinesis (Kishi
et al., 1993; Mabuchi et al., 1993), cell migration (Takaishi
et al., 1993, 1994), and gene expression (Hill et al., 1995).
Rho cycles between GDP-bound inactive and GTP-bound
active forms, and the GTP-bound form binds to specific
targets and then exerts its biological functions (Van Aelst
and D’Souza-Schorey, 1997; Hall, 1998; Kaibuchi et al.,
1999). Numerous putative Rho targets have been identi-
fied, including protein kinase N (Amano et al., 1996b; Wa-
tanabe et al., 1996), Rho-kinase/ROK
 
a
 
/ROCK II (Leung
et al., 1995; Ishizaki et al., 1996; Matsui et al., 1996), myo-
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sin-binding subunit (MBS)
 
1
 
 of myosin phosphatase (Ki-
mura et al., 1996), p140mDia (Watanabe et al., 1997), cit-
ron (Madaule et al., 1995), citron kinase (Madaule et al.,
1998), rhophilin (Watanabe et al., 1996), rhotekin (Reid
et al., 1996), Kv1.2 (Cachero et al., 1998), and phospholi-
pase D (Singer et al., 1997). ROK
 
b
 
/ROCK I is an isoform
of Rho-kinase (Ishizaki et al., 1996; Leung et al., 1996).
Myosin phosphatase is composed of MBS, a 37-kD type 1
phosphatase catalytic subunit and a 20-kD regulatory sub-
unit (Alessi et al., 1992; Hartshorne et al., 1998). Myosin
phosphatase binds to phosphorylated myosin light chain
(MLC) via MBS and dephosphorylates MLC. Rho-kinase
phosphorylates MBS, which leads to the inactivation of
myosin phosphatase in vitro (Kimura et al., 1996). Rho-
kinase by itself phosphorylates MLC at the same site that
is phosphorylated by MLC-kinase, and activates myosin
ATPase (Amano et al., 1996a). Thus, Rho-kinase and my-
osin phosphatase appear to regulate the phosphorylation
level of MLC, cooperatively. Consistently, the addition of
the dominant active Rho-kinase to permeabilized vascular
smooth muscle induces a contraction through MLC phos-
phorylation (Kureishi et al., 1997). In non-muscle cells, the
expression of dominant active Rho-kinase increases the
MLC phosphorylation, which in turn induces stress fiber
and focal adhesion formation in fibroblasts (Leung et al.,
1996; Amano et al., 1997; Chihara et al., 1997; Ishizaki et al.,
1997), and neurite retraction in neuronal cells (Amano
et al., 1998; Hirose et al., 1998; Katoh et al., 1998). In addi-
tion to MLC and MBS, Rho-kinase phosphorylates ERM
(ezrin/radixin/moesin) family proteins and adducin in vitro
(Matsui et al., 1998; Kimura et al., 1998). Myosin phos-
phatase interacts with both ERM family proteins and ad-
ducin through MBS, and dephosphorylates the phosphory-
lated ERM family proteins and adducin (Fukata et al.,
1998; Kimura et al., 1998). The phosphatase activity to-
ward ERM family proteins and adducin is inhibited when
MBS is phosphorylated by Rho-kinase as described for
MLC (Fukata et al., 1998; Kimura et al., 1998). Moreover,
we have found that the phosphorylation of moesin and ad-
ducin by Rho-kinase plays critical roles in the formation of
microvilli-like structures in fibroblasts (Oshiro et al., 1998)
and in membrane ruffling in MDCK cells (Fukata et al.,
1999), respectively. Based on these observations, we have
proposed the dual regulation model in which myosin phos-
phatase and Rho-kinase cooperatively regulate the phos-
phorylation state of the substrates including MLC, addu-
cin and moesin downstream of Rho. However, it remains
to be clarified how MBS phosphorylation is regulated
downstream of Rho in intact cells.
In this study, we determined the sites of phosphoryla-
tion of MBS by Rho-kinase, and prepared antibody that
specifically recognized MBS phosphorylated at Ser-854,
which was the specific site for Rho-kinase, to understand
 
how MBS phosphorylation is regulated in vivo. We found
by use of this antibody that MBS was phosphorylated by
Rho-kinase downstream of Rho in vivo
 
, 
 
and that phosphor-
ylated MBS was localized in the nucleus, cytoplasm and
membrane ruffling area in TPA-stimulated MDCK cells,
on stress fibers in interphase REF52 cells, and at the cleav-
age furrow in mitotic MDCK cells.
 
Materials and Methods
 
Materials and Chemicals
 
The expression plasmid of 
 
Botulinum
 
 C3 ADP-ribosyltransferase (pGEX-
C3) was kindly provided by Dr. A. Hall (University College London,
London, UK). The MDCK cells and the cDNA-encoding mouse moesin
(1–577 amino acids [aa]) were gifts from Dr. S. Tsukita (Kyoto University,
Kyoto, Japan). Monoclonal mouse anti-MBS Ab (anti-mMBS Ab; anti-
gen: 371–511 aa of M130) was kindly provided by Dr. D.J. Hartshorne
(University of Arizona, Tuscon, Arizona; Trinkle-Mulcahy et al., 1995;
Murata et al., 1997). HA1077 was kindly provided by Asahi Chemical In-
dustry (Shizuoka, Japan). Y-32885 was synthesized as described (Uehata
et al., 1997). Human recombinant hepatocyte growth factor (HGF) was
produced and purified as described (Nakamura et al., 1989; Seki et al.,
1990). TM71 (Goto et al., 1998), anti-pp2b Ab (Matsumura et al., 1998),
anti-pT558 Ab (Oshiro et al., 1998), anti-pT445 Ab (Fukata et al., 1999),
and polyclonal rabbit anti-MBS antibodies (anti-pnMBS Ab; antigen:
1–647 aa of M130 [Shimizu et al., 1994]/anti-pcMBS Ab; antigen: 758–
1032 aa of Rat3 MBS) were generated. A rabbit polyclonal antibody
against ERM (ezrin/radixin/moesin) family proteins (anti-ERM Ab) was
generated as follows. Glutathione-
 
S
 
-transferase-mouse moesin (GST-
mouse moesin; 357–577 aa)
 
 
 
was produced and purified from 
 
Escherichia
coli
 
 as an antigen. The obtained antiserum was then affinity-purified
against mouse moesin (357–577 aa). Anti-ERM Ab specifically recog-
nized ERM family proteins (data not shown). Protein kinase C (PKC) was
prepared from rat brain as described (Kitano et al., 1986). Phosphati-
dyl serine, bisbenzimide Hoechst, anti-MLC Ab, nocodazole, and N
 
6
 
,2
 
9
 
-
 
O
 
-dibutyryladenosine 3
 
9
 
:5
 
9
 
-cyclic monophosphate (dibutyryl cAMP) were
purchased from Sigma Chemical Co. 
 
g
 
-[
 
32
 
P]ATP was purchased from
Amersham Corp.
Tetradecanoylphorbol-13-acetate (TPA) and calyculin A were pur-
chased from Wako Pure Chemical Industries, Ltd. All materials used in
the nucleic acid study were purchased from Takara Shuzo Co. Other ma-
terials and chemicals were obtained from commercial sources.
 
Preparation of Recombinant Proteins
 
GST-catalytic domain of Rho-kinase (GST-CAT; 6–553 aa) and full-
length Rat3 MBS (1–1032 aa; Johnson et al., 1997) were produced in
 
Spodoptera frugiperda
 
 cells in a baculovirus system and purified as de-
scribed (Matsuura et al., 1987; Amano et al., 1996a; Fukata et al., 1998).
Maltose-binding protein-RB/PH(TT) [MBP-RB/PH(TT); 941–1388 aa],
GST-MBS-NH
 
2
 
-terminal domain (GST-MBS-NT; 1–763 aa), GST-MBS-
COOH-terminal domain (GST-MBS-CT; 758–1032 aa), GST-MBS-
CT
 
S854A, T855A 
 
(GST-MBS-CT AA),
 
 
 
GST-RhoA
 
I41
 
 and GST-C3 were
produced and purified from 
 
E
 
.
 
 coli
 
. For microinjection, GST-C3 and
GST-RhoA
 
I41
 
 were cleaved with thrombin, and purified to remove the
GST. MBP-RB/PH(TT), C3 and RhoA
 
I41 
 
were concentrated, and during
the concentration the buffer was replaced by microinjection buffer
(20 mM Tris-HCl at pH 7.4, 20 mM NaCl, 1 mM MgCl
 
2
 
, 0.1 mM EDTA,
and 5 mM 2-mercaptoethanol). For incubation, the buffer of C3 was re-
placed by PBS. The guanosine 5
 
9
 
-(3-
 
O
 
-thio)triphosphate (GTP
 
g
 
S) bound
form of RhoA
 
I41 
 
was prepared as described (Takaishi et al., 1993).
 
Phosphorylation Assay and Determination of the Sites 
of Phosphorylation of MBS by Rho-Kinase
 
The kinase reaction for Rho-kinase was carried out in 50 
 
m
 
l of kinase
buffer A (50 mM Tris-HCl at pH 7.5, 5 mM MgCl
 
2, 
 
1 mM EDTA, 1 mM
EGTA, and 1 mM DTT) containing 100 
 
m
 
M 
 
g
 
-[
 
32
 
P]ATP (1–20 GBq/
mmol), 5 pmol of GST-CAT and 20 pmol of GST-MBS-NT, GST-MBS-
CT, GST-MBS-CT AA, or full-length MBS. The kinase reaction for PKC
was carried out in 50 
 
m
 
l of kinase buffer B (25 mM Tris-HCl at pH 7.5, 4
mM MgCl
 
2
 
, 400 nM CaCl
 
2
 
, 150 nM TPA, 10 
 
m
 
g/ml phosphatidyl serine,
 
1. 
 
Abbreviations used in this paper:
 
 aa, amino acids; C3, 
 
Botulinum
 
 C3
ADP-ribosyltransferase; CAT, the catalytic domain of Rho-kinase; dibu-
tyryl cAMP, N
 
6
 
,2
 
9
 
-
 
O
 
-dibutyryladenosine 3
 
9
 
:5
 
9
 
-cyclic monophosphate;
ERM family proteins, ezrin/radixin/moesin; GST, glutathione-
 
S
 
-trans-
ferase; GTP
 
g
 
S, guanosine 5
 
9
 
-(3-
 
O
 
-thio)triphosphate; HGF, hepatocyte
growth factor; MBP, maltose-binding protein; MBS, myosin-binding sub-
unit; MLC, myosin light chain; PKC, protein kinase C; Rho-kinase, Rho-
associated kinase; TPA, tetradecanoylphorbol-13-acetate; TRITC, tet-
ramethylrhodamine B isothiocyanate. 
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and 1 mM DTT) containing 100 
 
m
 
M 
 
g
 
-[
 
32
 
P]ATP (1–20 GBq/mmol), 5
pmol of PKC, and 20 pmol of full-length MBS. After an incubation for 15
min at 30
 
8
 
C, the reaction products were boiled in SDS sample buffer and
aliquots of the reaction products were subjected to SDS-PAGE. The ra-
diolabeled bands were visualized and estimated by an image analyzer
(BAS-2000; Fuji).
To determine the sites of phosphorylation of MBS, the recombinant
full-length MBS (1 nmol of protein) was phosphorylated with GST-CAT
(200 pmol of protein) in 1 ml of kinase buffer A containing 100 
 
m
 
M
 
g
 
-[
 
32
 
P]ATP for 1 h at 30
 
8
 
C, and the reaction product was digested with
 
Achromobacter
 
 protease I at 37
 
8
 
C for 20 h. The obtained peptides were
applied onto a C18 reverse phase column (SG120; 4.6 
 
3
 
 250 mm; Shiseido)
and eluted with a linear gradient of 0–48% acetonitrile for 100 min at a
flow rate of 1.0 ml/min by high-performance liquid chromatography (Sys-
tem Gold; Beckman). The radioactive peptides were separated and phos-
phoamino acid sequencing was carried out with a peptide sequencer
(PPSQ-10; Shimazu). The fractions obtained from each Edoman degrada-
tion cycle were measured for 
 
32
 
P in a Beckman liquid scintillation counter.
 
Production of Site- and Phosphorylation State-specific 
Antibody for MBS
 
A rabbit polyclonal antibody against MBS phosphorylated at Ser-854
(anti-pS854 Ab) was prepared as described (Inagaki, M., et al., 1997). The
phosphopeptide Cys-Arg
 
849
 
-Glu-Lys-Arg-Arg-phosphoSer
 
854
 
-Thr-Gly-
Val-Ser-Phe
 
859 
 
was chemically synthesized as an antigen and bound to the
carrier protein, keyhole limpet hemocyanin at the NH
 
2
 
-terminal cysteine
residue, by Peptide Institute Inc. The obtained antiserum was then affin-
ity-purified against the phosphopeptide.
 
Cell Culture
 
MDCK cells were grown in DME containing 10% calf serum, penicillin
and streptomycin in an air-5% CO
 
2
 
 atmosphere at constant humidity.
REF52 cells were grown in DME containing 10% fetal bovine serum,
penicillin, and streptomycin in an air-5% CO
 
2
 
 atmosphere at constant hu-
midity.
 
Detection of Phosphorylated MBS in MDCK Cells by 
Immunoblot Analysis
 
We employed the conditions for C3 treatment as described (Nishiki et al.,
1990; Morii and Narumiya, 1995; Amano et al., 1996b) with slight modifi-
cations. MDCK cells were seeded at a density of 4.0 
 
3
 
 10
 
5 
 
cells in 6-cm
dishes and incubated for 24 h. Then, the cells were deprived of serum for
24 h. For the C3 treatment, the seeded cells were incubated first for 8 h,
and then in the presence of various doses of C3 for 16 h. Next, the cells
were deprived of serum for 24 h in the presence of C3. For some experi-
ments, serum-deprived cells were treated with various doses of HA1077
or Y-32885 for 30 min. The cells were then incubated in DME containing
200 nM TPA or 50 pM HGF at 37
 
8
 
C for various periods. The TPA- or
HGF-treated cells were treated with 10% (wt/vol) trichloroacetic acid.
The resulting precipitates were subjected to immunoblotting with anti-
pS854 Ab and anti-pnMBS Ab.
 
Subcellular Fractionation
 
MDCK cells were seeded at a density of 1.2 
 
3
 
 10
 
6 
 
cells in 10-cm dishes.
Non- and TPA-stimulated MDCK (5 
 
3
 
 10
 
7
 
) cells were fractionated as de-
scribed (Chen et al., 1992) with slight modifications. In brief, cells were
washed and homogenized in buffer H (20 mM Hepes at pH 7.4, 5 mM
KCl, 1 mM MgCl
 
2
 
, 50 mM NaF, 30 mM sodium pyrophosphate, 20 
 
m
 
g/ml
leupeptin, 50 
 
m
 
g/ml PMSF, 1 mM DTT, and 0.1 
 
m
 
M calyculin A) with
dounce homogenizer. The homogenates were loaded onto 1 M sucrose in
buffer H, and centrifuged at 1,600 
 
g
 
 for 10 min. The precipitates contained
nuclei. The supernatant fluids were further centrifuged at 100,000 
 
g
 
 for 30
min. The resulting supernatants were used as cytoplasmic fraction. The re-
sulting precipitates were used as membrane fraction. The precipitates con-
taining nuclei were resuspended with 1 M sucrose in buffer H, and centri-
fuged at 1,600 
 
g
 
 for 5 min. The resulting precipitates were used as nuclear
fraction. We confirmed by phase contrast microscopy that nuclear fraction
contained nearly the pure nuclei, and by immunoblot analysis of nuclear
(CREB), cytoplasmic (Rho GDI), and membrane (E-cadherin) marker
proteins that subcellular fractionation was successful (Montminy and
Bilezikjian, 1987; Nagafuchi et al., 1987; Ueda et al., 1990).
 
Preparation of Interphase, Early Mitotic, and Later 
Stages of Cell Division Cells
 
MDCK cells in interphase, early mitotic (metaphase), and later stages of
cell division cells were prepared as described (Bauer et al., 1998; Goto et al.,
1998) with slight modifications. MDCK cells were seeded at a density of
1.2 
 
3
 
 10
 
6
 
 cells in a 10-cm dish, and cultured for 24 h. Nocodazole was
added directly to the medium at 0.33 
 
m
 
M, and then cells were cultured for
additional 11 h. Mitotic cells were collected with PBS containing 4 mM
EGTA and 0.33 
 
m
 
M nocodazole by mechanical shake off, and adherent
cells were used as interphase cells. Mitotic cells were rinsed twice and sus-
pended with nocodazole free medium, and plated onto the dishes. Cells at
0, 30, 60, or 90 min after removal of nocodazole were used as early mitotic
and later stages of cell division cells. These cells were treated with 10%
(wt/vol) trichloroacetic acid as described above.
 
Immunofluorescence Analysis
 
MDCK cells were fixed with 3.0% formaldehyde in PBS for 20 min and
treated with PBS containing 0.2% Triton X-100 for 10 min on ice or ace-
tone for 10 min at 
 
2
 
20
 
8
 
C (for anti-pp2b Ab). REF52 cells were fixed with
3.0% formaldehyde in PBS for 10 min and treated with PBS containing
0.2% Triton X-100 for 10 min at room temperature. After being washed
with PBS three times, the cells were incubated with anti-pS854 Ab, anti-
pnMBS Ab, anti-pT558 Ab, anti-ERM Ab, anti-pp2b Ab, or anti-MLC
Ab at 4
 
8
 
C overnight, TM71 for 2 h at room temperature, or anti-mMBS
Ab for 1 h at room temperature. The cells were washed with PBS three
times, then incubated with fluorescein isothiocyanate (FITC)-conjugated
anti–rabbit or –mouse Ig Ab, Texas red–conjugated anti–rabbit, –mouse,
or –rat Ig Ab for 1 h at room temperature or tetramethylrhodamine B
isothiocyanate (TRITC)-phalloidin for 30 min at room temperature. DNAs
were stained with 1 
 
m
 
g/ml of bisbenzimide Hoechst for 3 min at room tem-
perature. Fluorescently labeled cells were examined with a Zeiss LSM510
(Carl Zeiss). In some experiments, fluorescent images (Figs. 4 and 5) were
taken with PXL cooled CCD camera (Photometrics) with DeltaVision
processing software (Applied Precision Inc.). Exposure time was adjusted
to obtain FITC and Texas red or rhodamine images with roughly equal in-
tensities in nonstimulated MDCK cells (see Fig. 4 A, a and b, and B, a and
b, respectively; checked by histogram analysis). Under the same condi-
tion, the images of TPA- or HGF-stimulated MDCK cells were taken. The
images of Figs. 4 A and 5 A, or Figs. 4 B and 5 B were treated with same
establishment of contrast and brightness, respectively. Grayscale FITC
and Texas red images were converted into green and red images, respec-
tively, and then merged to synthesize RGB color images. A ratio image
was created using an Image-Pro image processing system (Media Cyber-
netics). A grayscale image of anti-pS854 Ab was divided by a correspond-
ing grayscale image of anti-mMBS Ab, and the resultant image was multi-
plied by 50.
 
Microinjection
 
REF52 cells were seeded at a density of 3 
 
3
 
 10
 
3
 
 cells per 13-mm cover
glass in 6-cm dishes and incubated for 48 h. MBP (5 mg/ml), C3 (0.1 mg/ml),
C3 (0.1 mg/ml) plus GTP
 
g
 
S·RhoA
 
I41 
 
(0.4 mg/ml), or MBP-RB/PH(TT) (5
mg/ml) was microinjected along with a marker protein (rabbit or mouse
IgG at 1 mg/ml) into the cytoplasm of cells. After injection, the cells were
incubated at 37
 
8
 
C for 30 min, and fixed as described above.
 
Results
 
Determination of the Sites of Phosphorylation of MBS 
by Rho-Kinase
 
We first determined the sites of phosphorylation of MBS
by Rho-kinase in vitro as follows. Full-length MBS was ex-
pressed in 
 
Spodoptera frugiperda
 
 cells in a baculovirus sys-
tem and purified. Purified MBS was then incubated with
the GST-catalytic domain of Rho-kinase (GST-CAT; 6–553
aa). CAT has been previously shown to be constitutively
active in vitro and in vivo (Amano et al., 1996a, 1997).
Phosphorylated MBS was digested with 
 
Achromobacter
 
protease I and subjected to high-performance liquid chro- 
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matography. Two major (AP-3 and -4) and 6 minor (AP-1,
-2 and -5–8) radioactive peptides were obtained (Fig. 1).
As shown in Table I, we identified 14 phosphorylation sites
of MBS by Rho-kinase. Thr-697 and Ser-854 turned out to
be the major phosphorylation site in AP-3 and AP-4, re-
spectively. When GST-MBS-NT (1–763 aa) or CT (758–
1032 aa) was used as a substrate instead of full-length
MBS, the essentially similar results were obtained (data
not shown). Taking our previous studies and this result
into consideration, the consensus sequence of Rho-kinase
phosphorylation site is RXXS/T or RXS/T (Amano et al.,
1996a; Goto et al., 1998; Matsui et al., 1998; Fukata et al.,
1999). Rho-kinase seems to require the basic amino acid
such as Arg close to its phosphorylation site. It has been
previously reported that MBS is phosphorylated by pro-
tein kinase A (PKA), protein kinase C (PKC), and the en-
dogenous kinase that is copurified with MBS from chicken
gizzard (Ichikawa et al., 1996; Ito et al., 1997). MBS is
phosphorylated at Thr-850 of Chicken M133, which corre-
sponds to Thr-855 (one of the phosphorylation sites in AP-
4) of Rat3 MBS, by PKA (Ito et al., 1997). The sites of
phosphorylation of MBS by PKC are unknown. It should
be noted that Thr-697 (a major phosphorylation site in
AP-3) corresponds to Thr-695 of Chicken M133, has been
shown to be phosphorylated by the endogenous kinase
(Ichikawa et al., 1996). The phosphorylation of chicken
MBS by the endogenous kinase results in inhibition of my-
osin phosphatase (Ichikawa et al., 1996). Thus, the phos-
phorylation of MBS at Thr-697 by Rho-kinase may result
in inhibition of myosin phosphatase. The endogenous ki-
nase has not been identified. However, the endogenous ki-
nase appears to be distinct from Rho-kinase because some
characters of the endogenous kinase are different from
those of Rho-kinase (Amano, M., and K. Kaibuchi, un-
published data; Ichikawa et al., 1996).
 
Production and Characterization of the Site- and 
Phosphorylation State-specific Antibody for MBS
 
To investigate how the phosphorylation of MBS by Rho-
 
kinase is regulated in vivo, we prepared the site- and phos-
phorylation state-specific antibody for MBS. As shown in
Table I, Rho-kinase phosphorylated multiple sites of MBS
in vitro. Thr-697 was one of the major sites of phosphoryla-
tion of MBS by Rho-kinase in vitro. However, we can not
distinguish the phosphorylation of Thr-697 by Rho-kinase
and the endogenous kinase in vivo
 
 
 
as described above.
Ser-854, which was also one of the major sites of phos-
phorylation of MBS by Rho-kinase in vitro
 
,
 
 is the phos-
phorylation site specific to Rho-kinase among known
MBS kinases in vitro (We confirmed that PKC did
not phosphorylate MBS at Ser-854: see below). The phos-
phorylation at Ser-854 can serve as a pertinent indicator
to study MBS phosphorylation by Rho-kinase in vivo.
Thus, we prepared the rabbit polyclonal antibody (anti-
 
Table I. Amino Acid Sequences of Phosphopeptides Derived from Rho-Kinase Phosphorylated Rat3 MBS
 
Peptide
no. Amino acid sequence*
Phosphorylated
residues
 
‡
 
Relative amount
of phosphate in
peptide
 
§
 
% total
 
AP-1 NASRIESLEQEK
(residue 330–341)
Ser-332 3.4
AP-2 DTAGVIRSASSPRLSSSLDNK
(residue 463–483)
Ser 472 8.5
AP-3 ARSRQARQSRRSTQGVTLTDLQEAEK
(residue 685–710)
Ser-693, Ser-696, Thr-697 23.5
AP-4 RRSTGVSFWTQDSDENEQERQSDTEDGSSK
(residue 852–881)
Ser-854, Thr-855 22.0
AP-5 TGSYGALAEITASKEAQK
(residue 443–460)
Thr-443, Ser-445 6.0
AP-6 RDTQTDSVSRYDSSSTSSSDRYDSLLGRSASYSYLEERK
(residue 882–920)
Thr-884, Ser-894, Ser-905 11.5
AP-7 ND 3.2
AP-8 YSRTYDETYARYRPVSTSSSSTPSSSSLSTLGSSLYASSQLNRPNSLVGITSAYSRGLTK
(residue 759–818)
Thr-762, Ser-774 3.7
 
*Residue numbers correspond to Rat3 MBS.
 
‡
 
The residues that showed the highest radioactivity in each peptide are underlined.
 
§
 
Determined from radioactivity in the HPLC analysis as shown in Fig. 1. Total is not 100% because the amount of minor peaks is excluded.
Figure 1. Determination of the sites of phosphorylation of MBS
by Rho-kinase. Purified full-length MBS was incubated with
GST-CAT in kinase buffer A containing 100 mM g-[32P]ATP for
1 h at 308C, and the reaction product was digested with Achromo-
bacter protease I. The obtained peptides were applied onto a C18
reverse phase column as described in Materials and Methods. 
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pS854 Ab), raised against the synthetic phosphopeptide
(CEKRRphoshoS
 
854
 
TGVSF). The specificity of anti-
pS854 Ab was examined by immunoblot analysis. Equal
amounts of GST-MBS-CT with various ratios between
phosphorylated and unphosphorylated forms were loaded
on the gel. GST-MBS-CT phosphorylated by GST-CAT in
vitro was specifically detected by anti-pS854 Ab in a dose-
dependent manner (Fig. 2 A). The binding was neutralized
by preincubation of the antibody with the antigen phos-
phopeptide. We also confirmed that anti-pS854 Ab recog-
nized neither GST-MBS-CT
 
S854A, T855A
 
 (substitution of
residues by Ala), GST-MBS-NT phosphorylated by GST-
CAT (Fig. 2 A) nor full-length MBS phosphorylated by
PKC (Fig. 2 B). These results indicate that anti-pS854 Ab
specifically recognizes MBS phosphorylated at Ser-854 by
Rho-kinase.
 
Rho-Kinase–dependent Phosphorylation of MBS in 
MDCK Cells
 
Rho/Rho-kinase are implicated in HGF- and phorbol es-
ter–induced membrane ruffling in MDCK and KB epithe-
lial cells (Nishiyama et al., 1994; Takaishi et al., 1995;
Fukata et al., 1999). We examined whether MBS was
phosphorylated at Ser-854 via the Rho/Rho-kinase path-
way in vivo. When total cell lysate of nonstimulated
MDCK cells was immunoblotted with anti-pS854 Ab,
MBS phosphorylated at Ser-854 was weakly detected. The
addition of TPA enhanced the phosphorylation of MBS at
Ser-854 (Fig. 3 A). Similar results were obtained when the
cells were stimulated with HGF. A minor band with ap-
parent relative molecular mass of 90 kD was also detected.
This minor band may be a degradation product of MBS,
because the immunoreactive band detected by anti-MBS
Ab was found at the same position (data not shown). Af-
ter TPA stimulation, the phosphorylation level of MBS at
Ser-854 elevated within 3 min, reached maximum at 
 
z
 
30
min, and was sustained for at least 2 h (Fig. 3 B). The max-
imal phosphorylation level of MBS at Ser-854 was about
fivefold the basal level. The stoichiometries of phosphory-
lation at Ser-854 were z0.04 at the basal level and z0.20
at the maximal level, respectively. Similar results were ob-
tained when the cells were stimulated with HGF, although
the level of MBS phosphorylation induced by HGF was
slightly lower than that induced by TPA (Fig. 3 B). We
also confirmed that the addition of dibutyryl cAMP did
not induce the phosphorylation of MBS at Ser-854 (Fig. 3
A), whereas it induced the phosphorylation of cAMP-
response element binding protein (CREB) at Ser-133 (data
not shown). These results indicate that MBS is phosphory-
lated during the action of TPA and HGF in MDCK cells.
We furthermore examined whether MBS was phosphor-
ylated at Ser-854 via the Rho/Rho-kinase pathway dur-
ing the action of TPA and HGF in MDCK cells (Fig. 3
C). Botulinum C3 ADP-ribosyltransferase (C3), which is
thought to interfere with endogenous Rho functions, in-
hibited the focal adhesion formation in MDCK cells
(z50% inhibition by incubation of 100 mg/ml of C3; data
not shown). Under the conditions, the TPA-induced MBS
phosphorylation was inhibited to a similar extent (Fig. 3
C). A similar inhibition was observed when the cells were
pretreated with HA1077 or Y-32885, both of which are in-
hibitors of Rho-kinase (Fig. 3 C; Uehata et al., 1997).
Distribution of Phosphorylated MBS in MDCK Cells
We investigated the subcellular distribution of MBS phos-
phorylated at Ser-854 in MDCK cells. In the nonstimu-
lated MDCK cells, the immunoreactivity of phosphory-
lated MBS was strong in the nucleus and diffuse in the
cytoplasm, but not detected in cell–cell contact sites and
free end of plasma membrane (Fig. 4 A, a). The TPA-
induced membrane ruffling was detectable within 5 min
and reached maximum at 15 min of exposure to TPA in
the outer cell edge colonies (Nishiyama et al., 1994). Un-
der the conditions, the addition of TPA enhanced the im-
munoreactivity of phosphorylated MBS in the cytoplasm,
and the immunoreactivity of phosphorylated MBS was
weakly detected in the membrane ruffling area (Fig. 4 A,
c, arrowhead), where F-actin (Fig. 4 A, d, arrowhead),
Figure 2. Specificity of phos-
phorylation site-specific anti-
body (anti-pS854 Ab). (A)
Recognition of MBS phos-
phorylated at Ser-854. A total
of 200 fmol of GST-MBS-CT
(CT: 758–1032 aa) containing
the indicated amounts of
GST-MBS-CT phosphory-
lated by GST-CAT and 200
fmol of GST-MBS-CTS854A,
T855A (AA) and GST-MBS-
NT (NT: 1–763 aa) phos-
phorylated by GST-CAT
were resolved by SDS-PAGE
followed by immunoblotting
with anti-pS854 Ab (upper
panels), anti-pS854 Ab absorbed with a 100-fold amount of antigen phosphopeptide (middle panels) or anti-pnMBS or pcMBS Ab
(lower panels). (B) Specific recognition of MBS phosphorylated by Rho-kinase. A total of 4 pmol of full-length MBS (1–1032 aa) phos-
phorylated by GST-CAT (CAT) or PKC was resolved by SDS-PAGE followed by immunoblotting with anti-pS854 Ab (upper panel)
or anti-pnMBS Ab (lower panel) or by autoradiography (middle panel). The arrowhead indicates the position of MBS phosphorylated
at Ser-854. These results are representative of three independent experiments.The Journal of Cell Biology, Volume 147, 1999 1028
MBS (Fukata et al., 1998) and phosphorylated a-adducin
accumulated (Fukata et al., 1999). Similar results were ob-
tained when the cells were stimulated with HGF instead of
TPA (Fig. 4 A, e and f; arrowheads). The immunoreactiv-
ity of phosphorylated MBS in the nucleus, cytoplasm and
membrane ruffling area was abolished by preincubation of
the antibody with the antigen phosphopeptide (Fig. 4 A, g
and h).
Next, we compared the distribution of phosphorylated
and total MBS. In nonstimulated MDCK cells, the immu-
noreactivity of total MBS was strong in the cytoplasm (Fig.
4 B, b; Inagaki et al., 1997). In TPA-stimulated MDCK
cells, the immunoreactivity of total MBS was detected in
the cytoplasm and the TPA-induced membrane ruffling
area (Fig. 4 B, f; Fukata et al., 1998). The merged image of
anti-pS854 Ab (green) and anti-MBS Ab (red) immuno-
fluorescence enabled us to roughly estimate the phos-
phorylation state of MBS. Green, yellow, and red images
Figure 3. Rho- and Rho-kinase–
dependent phosphorylation of MBS
at Ser-854 in MDCK cells. (A) TPA-
and HGF-induced phosphorylation
of MBS at Ser-854. Serum-deprived
MDCK cells were stimulated with
200 nM TPA, 50 pM HGF for 15
min or 5 mM dibutyryl cAMP
(cAMP) for 30 min, and the whole-
cell lysates were resolved by SDS-
PAGE followed by immunoblotting
with anti-pS854 Ab (upper panel)
and anti-pnMBS Ab (lower panel).
Arrowhead indicates the position of
MBS phosphorylated at Ser-854. A
minor band with apparent relative
molecular mass of 90 kD may be a
degradation product of MBS. (B)
Time course of the phosphoryla-
tion of MBS at Ser-854 in the TPA-
and HGF-stimulated MDCK cells.
Serum-deprived MDCK cells were
stimulated with 200 nM TPA (a) or
50 pM HGF (b) for 3, 5, 15, 30, 60,
or 120 min, and the whole-cell lysates were resolved by SDS-PAGE followed by immunoblotting with anti-pS854 Ab (upper panels)
and anti-pnMBS Ab (lower panels). The amount of MBS phosphorylated at Ser-854 was quantitatively determined by scanning densi-
tometry. The densities of the immunoreactive bands with anti-pS854 Ab were normalized by that of total MBS. The mean density of the
immunoreactive bands with anti-pS854 Ab at 0 min was set at 100 arbitrary units. The values shown are means 6 SE of triplicates. (C)
Inhibition of the TPA- and HGF-induced MBS phosphorylation by C3 or Rho-kinase inhibitors. Nonpretreated (2), 50 or 100 mg/ml
C3-pretreated (3 and 4), 1 or 10 mM of HA1077-pretreated (5 and 6), or 1 or 10 mM of Y-32885–pretreated (7 and 8) serum-deprived
MDCK cells were stimulated with (2–8) or without (1) 200 nM TPA (a) or 50 pM HGF (b) for 15 min and the lysates were resolved by
SDS-PAGE followed by immunoblotting with anti-pS854 Ab (upper panels) and anti-pnMBS Ab (lower panels). The densities of the
immunoreactive bands with anti-pS854 Ab were normalized by that of total MBS. The mean density of the immunoreactive bands with
anti-pS854 Ab in the nonstimulated cells was set at 100 arbitrary units. The values shown are means 6 SE of triplicates.Kawano et al. Phosphorylation of MBS In Vivo 1029
indicate high, intermediate, and low levels of phosphoryla-
tion of MBS at Ser-854, respectively. The merged image of
phosphorylated and total MBS of the cytoplasm and free
end of plasma membrane in the TPA-stimulated cells was
more greenish than that of the cytoplasm in the nonstimu-
lated cells (Fig. 4 B, c and g). Consistently, the ratio (phos-
phorylated MBS/MBS) was high in cytoplasm and mem-
brane ruffling area of TPA-stimulated MDCK cells as
compared with that of nonstimulated MDCK cells (Fig. 4
B, d and h). The ratio in nucleus was also increased by
TPA stimulation. We found that phosphorylated MBS was
more enriched in the membrane ruffling area as compared
with Rho GDI, which is one of the cytoplasmic proteins
(data not shown; Ueda et al., 1990). Similar results were
obtained when the cells were stimulated with HGF instead
of TPA (Fig. 4 B, k and l).
To further determine the subcellular distribution of
phosphorylated MBS, we carried out the subcellular frac-
tionation analysis (Fig. 4 C). Total MBS was detected
mainly in cytoplasmic fractions in non- and TPA-stimu-
lated MDCK cells. The amount of total MBS in each frac-
tions of subcellular fractionation is consistent with the re-
sult of immunofluorescence study (Fig. 4, B and C). In
nonstimulated MDCK cells, phosphorylated MBS was
weakly detected in nuclear and cytoplasmic fractions. The
addition of TPA increased phosphorylated MBS mainly in
the cytoplasmic fraction and modestly in the nuclear frac-
tion. In addition, phosphorylated MBS was weakly de-
tected in membrane fraction. It should be also noted that
although the immunoreactivity of phosphorylated MBS in
immunofluorescence study was strong in the nucleus in the
presence or absence of TPA (Fig. 4, A and B), the phos-
phorylation level of MBS in the nuclear fraction in the
cells stimulated with TPA was lower than that in the cyto-
plasmic fraction in subcellular fractionation analysis (Fig.
4 C). This might be due to the rapid dephosphorylation of
MBS during nuclear isolation. Severe dephosphorylation
of MBS was not prevented during the subcellular fraction-
ation under the present conditions. Therefore, the amount
of phosphorylated MBS after subcellular fractionation
may be less than that of phosphorylated MBS in intact
cells. We found the additional band above phosphorylated
MBS in nuclear fraction. We do not know exactly whether
the additional band is an isoform of MBS or a nonspecific
band. In fact, Shimizu et al. identified two isoforms of
MBS (M130 and M133) from chicken gizzard (Shimizu et al.,
1994). The similar isoforms may exist in MDCK cells.
However, we could not rule out the possibility that pS854
Ab cross-reacted with other insoluble nuclear component
in immunofluorescence study.
Distribution of Phosphorylated MBS in Migrating 
MDCK Cells
We compared the subcellular distribution of phosphory-
lated MBS with that of F-actin and phosphorylated MLC
at Ser-19 in migrating MDCK cells. Between 2 and 16 h af-
ter the addition of TPA, the cells dissociated from each
other and migrated, with polarized morphology and mem-
brane ruffling in the leading edge. In the TPA-induced mi-
grating cells, phosphorylated MBS was localized in the
leading edge, where F-actin accumulated, and the poste-
rior region containing the nucleus (Fig. 5 A, a and b). Sim-
ilar results were obtained as to the distribution of phos-
phorylated MLC in migrating MDCK cells (Fig. 5 A, c and
d) as described (Matsumura et al., 1998). The merged im-
age of phosphorylated and total MBS in the leading edge
and the posterior region containing the nucleus in migrat-
ing MDCK cells was more greenish than that in the cyto-
plasm in the nonstimulated MDCK cells (Fig. 5 B, c and
Fig. 4 B, c). Consistently, the ratio (phosphorylated MBS/
MBS) was high in the leading edge and the posterior re-
gion containing the nucleus in migrating MDCK cells as
compared with that in nonstimulated MDCK cells (Fig. 4
B, d and Fig. 5 B, d).
Colocalization of Phosphorylated MBS, F-Actin, and 
Phosphorylated MLC in REF52 Fibroblasts
We further investigated the subcellular distribution of
phosphorylated MBS, F-actin, and phosphorylated MLC
in REF52 fibroblasts. REF52 cells grown in 10% fetal bo-
vine serum have thick actin stress fibers and vinculin-con-
taining focal adhesions, and show a filamentous periodical
pattern of myosin on stress fibers. We have previously shown
that total MBS is localized on stress fibers (Inagaki, N., et al.,
1997). Phosphorylated MBS was localized on stress fibers,
cortical actin filaments, and in the nucleus in REF52 cells
(Fig. 6 A, a). The double-immunostaining by TRITC-phal-
loidin and anti-pS854 Ab (Fig. 6 A, a and b) or anti-pp2b
Ab (Fig. 6 A, c and d) demonstrated coexistence of phos-
phorylated MBS, F-actin and phosphorylated MLC on
stress fibers and cortical actin filaments. The intracellular
localization of phosphorylated MBS is consistent with in
vitro binding of MBS and myosin (Alessi et al., 1992;
Shimizu et al., 1994). There was the difference in localiza-
tion of phosphorylated MBS between REF52 and MDCK
cells. REF52 cells highly developed thick stress fibers (Fig.
6 A, b), whereas serum-starved MDCK cells had a few
thin stress fibers (Fig. 4 A, b). Thus, phosphorylated MBS
might not be detected in stress fibers in MDCK cells. Next,
we compared the distribution of phosphorylated and total
MBS. The distribution of phosphorylated MBS was similar
to that of total MBS (Fig. 6 B, c). The ratio (phosphory-
lated MBS/MBS) image showed that the phosphorylation
level of MBS was high on stress fiber and in nucleus (Fig.
6 B, d).
We examined the effects of C3 and dominant negative
Rho-kinase [RB/PH(TT)] on the localization of phosphor-
ylated MBS in REF52 cells (Fig. 6 C). C3 ADP-ribosylates
Rho at Asn-41 and inactivates it, whereas RhoAI41 is not
ADP-ribosylated by C3 and is insensitive to C3. RB/
PH(TT) (941–1388 aa) is composed of Rho-binding (RB)
and pleckstrin-homology (PH) domains of Rho-kinase
(Matsui et al., 1996). RB/PH(TT), which has point muta-
tions in the RB domain and does not bind to Rho, inter-
acts with the kinase domain of Rho-kinase and thereby in-
hibits the Rho-kinase activity without titrating out Rho in
vitro (Amano et al., 1999). RB/PH(TT) functions as the
dominant negative form of Rho-kinase in vivo (Amano et
al., 1998). The microinjection of C3 into REF52 cells dis-
rupted the stress fibers and decreased the phosphorylated
MLC staining (Fig. 6 C, e and h) as described (Chihara
et al., 1997). The filamentous pattern of phosphorylatedThe Journal of Cell Biology, Volume 147, 1999 1030
Figure 4. Distribution of Ser-854–phosphory-
lated MBS in the TPA- or HGF-stimulated
MDCK cells. (A) Distribution of Ser-854–
phosphorylated MBS. Serum-deprived
MDCK cells were stimulated with 200 nM
TPA (c, d, and h) or 50 pM HGF (e and f) for
15 min. MDCK cells were stained with anti-
pS854 Ab (a, c, and e) or TRITC-phalloidin
(b, d, and f). MDCK cells were also stained
with anti-pS854 Ab absorbed with a 100-fold
amount of antigen phosphopeptide (g and h).
Arrowheads indicate the induced membrane
ruffling. (B) Distribution of phosphorylated
and total MBS. Serum-deprived MDCK cells
were stimulated with 200 nM TPA (e–h) or 50
pM HGF (i–l) for 15 min. MDCK cells were
doubly stained with anti-pS854 Ab (a, e, and
i) and anti-mMBS Ab (b, f, and j). The
merged (c, g, and k) and ratio (phosphory-
lated MBS/MBS; d, h, and l) images are
shown. (C) Subcellular distribution of phos-
phorylated MBS. Non- (2) and TPA- (1)
stimulated MDCK cells were separated into
nuclear (nucleus), cytoplasmic (cytoplasm),
and membrane (membrane) fractions, and
the fractions were immunoblotted with anti-
pS854 Ab (upper panel) and anti-pnMBS Ab
(lower panel). These results are representa-
tive of three independent experiments. Bars,
10 mm. Kawano et al. Phosphorylation of MBS In Vivo 1031
MBS was also perturbed by the microinjection of C3 (Fig.
6 C, f). Under these conditions, total MBS and MLC were
scattered in the cytoplasm (Fig. 6 C, g; Chihara et al.,
1997). The coinjection of GTPgS·RhoAI41 with C3 re-
versed the effects of C3 (Fig. 6 B, i–l). The microinjection
of RB/PH(TT) also disrupted the stress fibers (Fig. 6 C, m)
and decreased the staining of phosphorylated MBS and
MLC in REF52 cells (Fig. 6 C, n and p). Similar results
were obtained when cells were treated with Rho-kinase in-
hibitors (HA1077 and Y-32885) (data not shown). It
should be noted that the microinjection of C3 into REF52
decreased the staining of phalloidin in most cells, whereas
that of RB/PH(TT) induced the disorganization of actin
filaments (Fig. 6 C, m). C3 may induce depolymerization
of F-actin through the inhibition of other Rho-targets such
as p140mDia.
Distribution of Phosphorylated MBS and ERM Family 
Proteins during Cytokinesis
It has been shown that ERM family proteins and MLC
phosphorylated at Ser-19 highly accumulate at the cleav-
age furrow during cytokinesis (Sato et al., 1991; Mat-
sumura et al., 1998). In a recent study, we have found that
Rho-kinase also highly and circumferentially accumulates
at the cleavage furrow in various cell lines (Kosako et al.,
1999), and that dominant negative Rho-kinase inhibits the
progress of cytokinesis (Yasui et al., 1998). Here we exam-
ined the distribution of phosphorylated MBS during the
different mitotic stages of MDCK cells. Phosphorylated
MBS was enriched at the mid zone between the daughter
chromosomes in late anaphase and at the cleavage furrow
in telophase (Fig. 7 A, a and b). Phosphorylated MBS per-
sisted at the mid body until the end of cytokinesis (Fig. 7
A, c). Next, we compared the distribution of phosphory-
lated MLC and ERM family proteins to that of phosphor-
ylated MBS during different mitotic stages of MDCK cells.
The staining patterns of phosphorylated MLC were spa-
tially and temporally similar to that of phosphorylated
MBS in dividing cells (Fig. 7 A, g–i). Phosphorylated ERM
family proteins accumulated in the microvilli-like struc-
tures in the cell body at all stages as described (Oshiro et
al., 1998), and highly and circumferentially accumulated
around the mid zone in late anaphase, and the cleavage
furrow in telophase. The staining patterns of phosphory-
lated ERM family proteins were also similar to that of
phosphorylated MBS, but phosphorylated ERM family
proteins did not persist at the mid body until the end of cy-
tokinesis (Fig. 7 A, m–o). Vimentin is the most widely ex-
pressed intermediate filament protein, which is phosphor-
ylated by Rho-kinase at Ser-71 (Goto et al., 1998). Using
TM71, which recognizes the phosphorylation of vimentin
at Ser-71, vimentin is shown to be specifically phosphory-
lated at the cleavage furrow whereas total vimentin is
diffusely localized throughout the cytoplasm (Yasui et
al., 1998). Although phosphorylated vimentin, MBS and
ERM family proteins accumulated around the cleavage
furrow, they were not completely colocalized (Fig. 7 B, f
and l). Phosphorylated adducin, which is one of the Rho-
kinase substrates, was diffusely localized throughout the
cytoplasm (Fig. 7 B, m). It should be noted that total MBS
was diffusely localized throughout the cytoplasm, but not
accumulated at the cleavage furrow (Fig. 7 B, a). In con-
trast, phosphorylated MBS strongly accumulated at the
cleavage furrow (Fig. 7 B, d), indicating that MBS was
phosphorylated specifically at the cleavage furrow. Total
ERM family proteins was diffusely localized throughout
the cytoplasm, and at the microvilli and cleavage furrow
Figure 5. Distribution of
phosphorylated MBS in mi-
grating MDCK cells. (A) Se-
rum-deprived MDCK cells
were stimulated with 200 nM
TPA for 2 h. Migrating
MDCK cells were doubly
stained with TRITC-phalloi-
din (b and d) and anti-pS854
Ab (a) or anti-pp2b Ab (c).
(B) Localization of phosphor-
ylated and total MBS in mi-
grating MDCK cells. Migrat-
ing cells were doubly stained
with anti-pS854 Ab (a) and
anti-mMBS Ab (b). The
merged (c) and ratio (phos-
phorylated MBS/MBS; d) im-
ages are shown. Bars, 10 mm.The Journal of Cell Biology, Volume 147, 1999 1032
Figure 6. Colocalization of
phosphorylated MBS, F-actin
and phosphorylated MLC in
REF52 fibroblasts. (A) Lo-
calization of phosphorylated
MBS. REF52 cells were dou-
bly stained with TRITC-phal-
loidin (b and d) and anti-
pS854 Ab (a) or anti-pp2b Ab
(c). (B) Distribution of phos-
phorylated and total MBS in
REF52 cells. REF52 cells
were doubly stained with
anti-pS854 Ab (a) and anti-
mMBS Ab (b). The merged
(c) and ratio (phosphory-
lated MBS/MBS; d) images
are shown. (C) Inhibition of
phosphorylation of MBS by
C3 or dominant negative
Rho-kinase. REF52 cells
were microinjected with
MBP  (5.0 mg/ml) (a–d), C3
(0.1 mg/ml) (e–h), C3 plus
GTPgS·RhoAI41 (0.4 mg/ml)
(i–l), or MBP-RB/PH(TT)
(5.0 mg/ml) (m–p). REF52
cells were stained with
TRITC-phalloidin (a, e, i, and
m), anti-pS854 Ab (b, f, j, and
n), anti-pnMBS Ab (c, g, k,
and o), and anti-pp2b Ab (d,
h, l, and p). The arrowheads
indicate the injected cells.
Bars, 10 mm.Kawano et al. Phosphorylation of MBS In Vivo 1033
Figure 7. Distribution of phosphory-
lated MBS and ERM family proteins
during cytokinesis in MDCK cells. (A)
Accumulation of phosphorylated MBS
and ERM family proteins at the cleav-
age furrow. MDCK cells in late
anaphase (a, d, g, j, m, and p), telo-
phase (b, e, h, k, n, and q) or cytokine-
sis (c, f, i, l, o, and r; indicated by ar-
rowheads) stained with anti-pS854 Ab
(a–c), anti-pp2b Ab (g–i), or anti-
pT558 Ab (m–o) are shown. DNAs
were stained with bisbenzimide Hoechst
(d–f, j–l, and p–r). (B) Specific localiza-
tion of phosphorylated Rho-kinase
substrates during cytokinesis. MDCK
cells in cytokinesis doubly stained with
TM71 (b, e, h, k, and n) and anti-pnMBS
Ab (a), anti-pS854 Ab (d), anti-ERM
Ab (g), anti-pT558 Ab (j), and anti-
pT445 Ab (m). Merged images are
shown (c, f, i, l, and o). (C) Elevation
of phosphorylation of MBS at Ser-854
during cytokinesis. Total cell lysates
were prepared from interphase cells
(I), early mitotic cells (metaphase, M)
and cells at different stages of cell divi-
sion (time in minutes after the release
of mitotic arrest), and immunoblotted
with anti-pS854 Ab (upper panel) or
anti-pnMBS Ab (lower panel). These
results are representative of three in-
dependent experiments. Bars, 10 mm.The Journal of Cell Biology, Volume 147, 1999 1034
(Fig. 7 B, g), whereas phosphorylated ERM family pro-
teins accumulated at the microvilli and cleavage furrow
preferentially (Fig. 7 B, j). To further confirm that the
phosphorylation level of MBS at Ser-854 elevates during
the cytokinesis, immunoblot analysis of synchronized
MDCK cells lysates was carried out (Fig. 7 C). By release
from mitotic arrest by nocodazole, early mitotic cells syn-
chronistically entered into later stages of cell division, and
at 30 min after release of mitotic arrest, z40% of the cells
were in late anaphase, telophase or cytokinesis. At later
phases, the cells were in post mitotic spreading (60–180
min) as described (data not shown; Matsumura et al.,
1998). The immunoreactivity of anti-pS854 Ab was in-
creased at 30 min after release of mitotic arrest as com-
pared with that in interphase and early mitotic cells (Fig. 7
C). This increment of phosphorylation level of MBS was
reversed at 60 min.
Discussion
Phosphorylation of MBS by Rho-Kinase In Vitro
Here we identified Ser-854 as one of the major sites of
phosphorylation of MBS by Rho-kinase in vitro, and pre-
pared a rabbit polyclonal antibody (anti-pS854 Ab), raised
against the synthetic phosphopeptide. Anti-pS854 Ab
specifically recognized MBS phosphorylated by Rho-kinase,
but not by PKC in vitro. Since Ser-854 in MBS is the phos-
phorylation site specific to Rho-kinase among known
MBS kinases, the phosphorylation of MBS at Ser-854
appears to be a useful indicator of the Rho/Rho-kinase ac-
tivation in vivo. We found that Thr-697 was also one of the
major sites of phosphorylation of MBS by Rho-kinase in
vitro. We have previously reported that the phosphatase
activity toward MLC is inhibited when MBS is phosphory-
lated by Rho-kinase (Kimura et al., 1996). The endoge-
nous kinase that is copurified with MBS from chicken
gizzard (Ichikawa et al., 1996), phosphorylates MBS at
Thr-695 (M133), which corresponds to Thr-697 of Rat3
MBS, and thereby inactivates the phosphate activity (Ichi-
kawa et al., 1996). The phosphorylation of MBS at Thr-697
by Rho-kinase may result in inhibition of myosin phos-
phatase. The endogenous kinase appears to be distinct
from Rho-kinase because the endogenous kinase is not in-
hibited by H7, which is one of the PKC inhibitors, whereas
Rho-kinase is inhibited by H7 (unpublished data), and be-
cause the endogenous kinase but not Rho-kinase phos-
phorylates MLC at PKC sites (Amano et al., 1996a; Ich-
ikawa et al., 1996). Since several sites of MBS including
Thr-697 and Ser-854 were phosphorylated by Rho-kinase
in vitro, further studies are necessary to determine which
sites are the major sites of phosphorylation of MBS by
Rho-kinase in vivo, and which phosphorylation sites are
responsible for the inhibition of the phosphatase activity
by Rho-kinase in vitro and vivo.
Phosphorylation of MBS by Rho-Kinase In Vivo
We have previously shown that expression of dominant
active Rho in NIH 3T3 cells results in an increment of
MBS phosphorylation (Kimura et al., 1996). MBS is phos-
phorylated and the myosin phosphatase activity is inacti-
vated during the action of thromboxane A2 in platelets,
and both reactions are inhibited by a prior treatment of
platelets with C3 (Nakai et al., 1997). Similar observations
are obtained in endothelial cells during the action of
thrombin (Essler et al., 1998). Here we found by use of
anti-pS854 Ab that the stimulation of MDCK cells with
TPA or HGF induced the phosphorylation of MBS at Ser-
854, and that pretreatment of the cells with C3 or Rho-
kinase inhibitors inhibited the TPA- or HGF-induced
MBS phosphorylation. It is possible that TPA induced the
phosphorylation of MBS at Ser-854 through direct phos-
phorylation by PKC. However, this possibility is unlikely
because anti-pS854 Ab did not recognize MBS phosphor-
ylated by PKC in vitro. Phosphorylated MBS accumulated
on stress fibers in REF52 cells. The microinjection of C3
or dominant negative Rho-kinase into REF52 cells weak-
ened the accumulation of phosphorylated MBS. These re-
sults indicate that MBS is phosphorylated by Rho-kinase
downstream of Rho in non-muscle cells. Myosin phos-
phatase binds to phosphorylated Rho-kinase substrates
such as MLC via MBS and dephosphorylates them. Rho-
kinase phosphorylates MBS, which leads to the inactiva-
tion of myosin phosphatase in vitro (Kimura et al., 1996,
1998; Fukata et al., 1998). Taken together, these observa-
tions suggest that the phosphorylation of MBS by Rho-
kinase is involved in regulating the phosphorylation level
of Rho-kinase substrates in non-muscle cells.
Evidence is accumulating that Rho regulates the phos-
phorylation level of MLC through Rho-kinase and myosin
phosphatase in smooth muscle cells (Hirata et al., 1992;
Noda et al., 1995; Gong et al., 1996; Kureishi et al., 1997).
Because contraction of smooth muscle cells determines
the size of lumen in blood vessels, airways, the gastrointes-
tinal tract, uterus, and bladder, abnormal contraction can
cause diseases such as hypertension and asthma (Somlyo,
1997). It has recently been shown that Y-27632 (one of
the specific inhibitors for Rho-kinase) selectively inhibits
smooth muscle contraction and corrects blood pressure in
several hypertensive rat models (Uehata et al., 1997).
Thus, the Rho-kinase–mediated pathway appears to be in-
volved in the pathogenesis of hypertension. Phosphoryla-
tion of MBS by Rho-kinase may play an important role in
generating a certain types of abnormal contraction of
smooth muscle. In this regard, we have recently found that
Rho-kinase phosphorylates MBS at Ser-854 during por-
cine coronary artery spasm (Kandabashi et al., 1999).
Phosphorylation of MBS in Motile Cells
Membrane ruffling is observed in the leading edges of mo-
tile cells and is thought to be essential for cell motility
(Cooper, 1991). A force arising from actin polymerization
appears to drive lamellipodial protrusion (Mitchison and
Cramer, 1996), which is thought to be regulated by the
small GTPase Rac (Ridley et al., 1992; Hall, 1998). Actin
in the membrane ruffling area is thought to be continu-
ously depolymerized and then repolymerized during cell
movement (Mitchison and Cramer, 1996). A force derived
from myosin II driven by MLC phosphorylation, which is
thought to be regulated by Rho (Amano et al., 1996a,
1998) in the membrane ruffling area and posterior regionKawano et al. Phosphorylation of MBS In Vivo 1035
of motile cells may also contribute to cell movement
(Lauffenburger et al., 1996; Mitchison and Cramer, 1996).
Indeed, injection of anti–MLC-kinase Ab diminishes the
cell motility of macrophages (Wilson et al., 1991). More-
over, Matsumura et al. (1998) have recently shown that
the phosphorylation level of MLC is high in the leading
edge and posterior region containing the nucleus during
the cell migration. It has been previously reported that
the addition of TPA decreases force that the whole cell
applies to the substrate in certain migrating fibroblasts
(Danowski and Harris, 1988). The cycling between phos-
phorylated and nonphosphorylated states of MLC may be
necessary for cell migration. In this regard, we have re-
cently reported that microinjection of either dominant
negative or constitutively active Rho-kinase inhibits cell
migration of NRK cells (Fukata et al., 1999).
We have recently found that the microinjection of domi-
nant negative Rho-kinase inhibits the TPA- or HGF-
induced membrane ruffling in MDCK cells, indicating that
Rho-kinase is necessary for the cell motility (Fukata et al.,
1999). Here we found that MBS phosphorylated at Ser-854
as well as MLC phosphorylated at Ser-19 were localized in
the leading edge and posterior region in migrating MDCK
cells. We have recently found that phosphorylated a-addu-
cin accumulates in the leading edge in migrating MDCK
cells (Fukata et al., 1999). Myosin phosphatase interacts
with both MLC and adducin through MBS, and dephos-
phorylates the phosphorylated MLC and a-adducin (Ki-
mura et al., 1996, 1998). Taken together, the above obser-
vations suggest that myosin phosphatase and Rho-kinase
cooperatively regulate the MLC phosphorylation in the
leading edge and posterior region in migrating MDCK
cells, and the a-adducin phosphorylation in the leading
edge.
Phosphorylation of MBS in Fibroblasts
Rho-kinase is thought to regulate the formation of actin
stress fibers (Leung et al., 1996; Amano et al., 1997; Ish-
izaki et al., 1997). We have recently found that the expres-
sion of mutant MLCT18D, S19D (substitution of residues by
Asp), which is known to lead to the activation of myosin
ATPase and a conformational change of myosin II when
reconstituted with myosin heavy chain in vitro (Kami-
soyama et al., 1994; Sweeney et al., 1994; Bresnick et al.,
1995), also enhances the formation of stress fiber (Amano
et al., 1998). Thus, it is likely that the Rho/Rho-kinase
pathway plays a critical role in the formation of stress fiber
through myosin II activation. Here we found that phos-
phorylated MBS was localized on stress fibers in REF52
cells. The microinjection of C3 or dominant negative Rho-
kinase into REF52 cells disrupted stress fibers and weak-
ened the accumulation of phosphorylated MBS. These
observations suggest that myosin phosphatase and Rho-
kinase cooperatively regulate the MLC phosphorylation in
fibroblasts, which in turn induce the formation of stress
fiber.
Phosphorylation of MBS during Cytokinesis
Rho, Rho-kinase, and ERM family proteins accumulate at
the cleavage furrow (Sato et al., 1991; Takaishi et al., 1995;
Kosako et al., 1999), where MLC phosphorylation occurs
(Matsumura et al., 1998). The expression of C3 or domi-
nant negative Rho-kinase inhibits cytokinesis, resulting in
multiple nuclei (Kishi et al., 1993; Mabuchi et al., 1993;
Yasui et al., 1998). Thus, MLC phosphorylation by the
Rho/Rho-kinase pathway appears to provide contractility
to the contractile ring and to play a critical role in cyto-
kinesis. Rho-kinase also phosphorylates intermediate
filament proteins such as glial fibrillary acidic protein
(GFAP) and vimentin, exclusively at the cleavage furrow
during cytokinesis (Kosako et al., 1997; Goto et al., 1998).
The expression of GFAP mutated at Rho-kinase phosphor-
ylation sites induces impaired segregation of glial filament
into postmitotic daughter cells (Yasui et al., 1998). Thus,
Rho-kinase appears to be essential not only for cytokinesis
but also for the segregation of GFAP filaments into
daughter cells which in turn ensures efficient cellular sepa-
ration. Here we found that phosphorylated MBS as well as
phosphorylated ERM family proteins accumulated at the
cleavage furrow, where phosphorylated MLC and vimen-
tin accumulated. Indeed, the phosphorylation level of
MBS elevated during cytokinesis. Taken together, these
results suggest that myosin phosphatase spatiotemporally
regulates the phosphorylation state of certain substrates
including MLC and ERM family proteins during cytokine-
sis in cooperation with Rho-kinase under the control of
Rho. Recently, it has been shown that citron kinase, an-
other Rho-binding kinase with structural similarity in the
kinase domain to Rho-kinase, accumulates at the cleavage
furrow and may play an important role in the contractile
process during cytokinesis (Madaule et al., 1998). Further
analysis of different and redundant functions of both Rho-
binding kinases will help us to elucidate the molecular
mechanism underlying cytokinesis downstream of Rho.
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